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Abstract
Background: Postoperative pulmonary complications (PPCs) increase the morbidity and mortality of surgery in
obese patients. High levels of positive end-expiratory pressure (PEEP) with lung recruitment maneuvers may improve
intraoperative respiratory function, but they can also compromise hemodynamics, and the effects on PPCs are uncertain.
We hypothesized that intraoperative mechanical ventilation using high PEEP with periodic recruitment maneuvers, as
compared with low PEEP without recruitment maneuvers, prevents PPCs in obese patients.
Methods/design: The PRotective Ventilation with Higher versus Lower PEEP during General Anesthesia for Surgery in
OBESE Patients (PROBESE) study is a multicenter, two-arm, international randomized controlled trial. In total, 2013 obese
patients with body mass index ≥35 kg/m2 scheduled for at least 2 h of surgery under general anesthesia and at
intermediate to high risk for PPCs will be included. Patients are ventilated intraoperatively with a low tidal
volume of 7 ml/kg (predicted body weight) and randomly assigned to PEEP of 12 cmH2O with lung recruitment
maneuvers (high PEEP) or PEEP of 4 cmH2O without recruitment maneuvers (low PEEP). The occurrence of PPCs will
be recorded as collapsed composite of single adverse pulmonary events and represents the primary endpoint.
Discussion: To our knowledge, the PROBESE trial is the first multicenter, international randomized controlled trial to
compare the effects of two different levels of intraoperative PEEP during protective low tidal volume ventilation on
PPCs in obese patients. The results of the PROBESE trial will support anesthesiologists in their decision to choose a
certain PEEP level during general anesthesia for surgery in obese patients in an attempt to prevent PPCs.
Trial registration: ClinicalTrials.gov identifier: NCT02148692. Registered on 23 May 2014; last updated 7 June 2016.
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Background
It is well established that postoperative pulmonary com-
plications (PPCs), especially postoperative respiratory
failure, add greatly to perioperative morbidity and mor-
tality, as well as to postoperative length of hospital stay
[1–3]. Several independent risk factors for the develop-
ment of PPCs have been identified, ranging from a
patient’s health conditions to surgical approaches and
anesthetic management [4]. Considering that more than
234 million surgical procedures are performed world-
wide per year [5], a reduction of the rate of PPCs might
have an important impact on global morbidity and mor-
tality and reduce health system costs. Anesthetists could
importantly contribute to preventing such respiratory
complications, such as through intraoperative mechan-
ical ventilation strategies expected to affect PPCs beyond
preoperative patient status optimization and selection of
operative methods to minimize surgical trauma. In
fact, mechanical ventilation during general anesthesia
has the potential to cause harm to previously nonin-
jured lungs [4].
Authors of an individual patient data meta-analysis
showed that intraoperative lung-protective mechanical
ventilation using lower tidal volume (VT) in the range of
6 to 8 ml/kg of predicted body weight (PBW), with or
without higher levels of positive end-expiratory pressure
(PEEP) and with or without lung recruitment maneuvers
(RMs), reduced the incidence of PPCs [2]. More re-
cently, authors of another individual patient data meta-
analysis identified the use of intraoperative low VT as a
protective measure against PPCs, whereas the role of
PEEP was unclear [6]. In fact, in a randomized con-
trolled trial with patients with body mass index (BMI)
<40 kg/m2 undergoing open abdominal surgery, higher
PEEP with RMs did not prevent PPCs compared with
lower PEEP without RMs [7].
BMI is an important determinant of respiratory func-
tion before and during anesthesia in obese patients [8–
10]. In these patients, lung function impairment can
manifest as (1) reduced lung volume with increased atel-
ectasis and/or small airway closure; (2) derangements in
respiratory system, lung, and chest wall compliance as
well as increased resistance; and (3) moderate to severe
hypoxemia. These physiological alterations are more
marked in obese patients with hypercapnia or obstruct-
ive sleep apnea (OSA). To reduce such complications,
PEEP levels should theoretically be set higher in obese
than in nonobese patients. However, there is as yet no
clinical evidence supporting such an approach. An ob-
servational study conducted in 28 centers in France re-
vealed that most patients undergoing general surgery,
including obese patients, were ventilated with low PEEP
(≤4 cmH2O) or even without PEEP, even though average
PEEP was higher in obese than in nonobese patients
[11]. In fact, current recommendations on the use of
PEEP and RMs [4, 12] are derived from trials that in-
cluded mainly patients with BMI <35 kg/m2 and there-
fore cannot be extrapolated to obese patients.
The aim of the PRotective Ventilation with Higher versus
Lower PEEP during General Anesthesia for Surgery in
OBESE Patients (PROBESE) trial is to compare the effects
of two intraoperative mechanical ventilation strategies on
PPCs, extrapulmonary postoperative complications (PEPCs),
and length of hospital stay, as well as intraoperative lung
function and hemodynamics, in surgical patients with BMI
≥35 kg/m2. We hypothesized that intraoperative mech-
anical ventilation using high PEEP with periodic RMs,
as compared with low PEEP without RMs, prevents
PPCs in obese patients.
Methods/design
Objectives and design
PROBESE is a prospective international multicenter,
randomized, controlled, two-arm trial initiated by in-
vestigators of the PROtective VEntilation NETwork
(www.provenet.eu). In total, 2013 patients will be ran-
domly assigned to one of two different intraoperative
mechanical ventilation strategies (see Consolidated Stan-
dards of Reporting Trials [CONSORT] diagram, Fig. 1).
The PROBESE trial will test the hypothesis that, during
an intraoperative lung-protective mechanical ventilation
strategy with low VT s, higher levels of PEEP and RMs, as
compared with ventilation with lower levels of PEEP with-
out RMs, reduce PPCs in obese patients at intermediate to
severe risk for PPCs. After starting the trial, recalculation of
the sample size was conducted upon a recommendation of
the Data and Safety Monitoring Board (DSMB) (see “Sam-
ple size calculations” section). There were changes in nei-
ther the study protocol (version 2.5; February 2016,
Additional file 1) nor any of the endpoints. A complete
checklist of recommended items to address in a clinical trial
protocol and related documents according to the "Standard
Protocol Items: Recommendations for Interventional Trials
(SPIRIT) 2013 is provided in Additional file 2.
Study population
Investigators screen for obese patients with BMI ≥35 kg/
m2 scheduled for surgery under general anesthesia.
Patients are eligible if the expected duration of surgery
(from incision to closure) exceeds 2 h and if they are at
intermediate to high risk for PPCs. The number of pa-
tients meeting these enrollment criteria will be recorded.
To identify patients at risk for PPCs, the Assess
Respiratory Risk in Surgical Patients in Catalonia
(ARISCAT) score is used [13]. This score predicts indi-
vidual preoperative risk for PPCs using seven independ-
ent predictors, four of which are patient-related and
three of which are surgery-related (Table 1). An ARISCAT
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risk score ≥26 is associated with an intermediate to high
risk for PPCs.
Patients are excluded from participation if they are aged
<18 years, have undergone any kind of previous lung sur-
gery, have been invasively mechanically ventilated for lon-
ger than 30 minutes within the last 30 days before surgery,
or have received recent immunosuppressive medication
(chemotherapy or radiation therapy up to 2 months prior
to surgery). Further exclusion criteria comprise neurosurgi-
cal procedures and cardiac surgery, need for one-lung ven-
tilation or planned reintubation following surgery, need for
intraoperative prone or lateral decubitus position, enroll-
ment in another interventional study, or refusal to give
written informed consent. Additionally, patients showing at
least one the following medical conditions are excluded:
pregnancy (excluded by anamnesis and/or laboratory ana-
lysis), persistent hemodynamic instability or intractable
shock (considered hemodynamically unsuitable for the
study by the patient’s managing physician), history of severe
chronic obstructive pulmonary disease (COPD; defined as
noninvasive ventilation and/or oxygen therapy at home or
repeated systemic corticosteroid therapy for acute
exacerbations of COPD), severe cardiac disease (defined as
New York Heart Association class III or IV, acute coronary
syndrome, or persistent ventricular tachyarrhythmia), con-
current acute respiratory distress syndrome (ARDS) ex-
pected to require prolonged postoperative mechanical
ventilation, severe pulmonary arterial hypertension (defined
as systolic pulmonary arterial pressure >40 mmHg), intra-
cranial injury, or tumor or neuromuscular disease.
Intervention
Patients undergo intraoperative lung-protective mechanical
ventilation with protective low VT of 7 ml/kg (PBW), and
they are randomly assigned to a PEEP level of 12 cmH2O
with planned lung RMs performed after intubation, hourly
thereafter and preceding extubation (“high PEEP”), or a
level of PEEP of 4 cmH2O without planned RMs (“low
PEEP”). PEEP levels are to be maintained throughout the
whole period of intraoperative mechanical ventilation.
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) diagram
for the PRotective Ventilation with Higher versus Lower PEEP during
General Anesthesia for Surgery in OBESE Patients (PROBESE) trial. PEEP
Positive end-expiratory pressure
Table 1 Assess Respiratory Risk in Surgical Patients in Catalonia
scores
Multivariate analysis,
OR (95% CI), n = 1624
β Coefficient Risk scorea
Age, years
≤50 1
51–80 1.4 (0.6–3.3) 0.331 3
>80 5.1 (1.9–13.3) 1.619 16
Preoperative SpO2, %
≥96 1
91–95 2.2 (1.2–4.2) 0.802 8
≤90 10.7 (4.1–28.1) 2.375 24
Respiratory infection
in the last month
5.5 (2.6–11.5) 1.698 17
Preoperative anemia
(≤10 g/dl)
3.0 (1.4–6.5) 1.105 11
Surgical incision
Peripheral 1
Upper abdominal 4.4 (2.3–8.5) 1.480 15
Intrathoracic 11.4 (4.9–26.0) 2.431 24
Duration of surgery, h
≤2 1
>2–3 4.9 (2.4–10.1) 1.593 16
>3 9.7 (4.7–19.9) 2.268 23
Emergency procedure 2.2 (1.04–4.5) 0.768 8
SpO2 Peripheral oxyhemoglobin saturation measured by pulse oximetry breathing
air in supine position
Independent predictors of risk for development of postoperative pulmonary
complications as described by Canet et al. [13] (ARISCAT score). A risk score ≥26
predicts an intermediate to high risk for postoperative pulmonary complications)
aThe simplified risk score is the sum of each logistic regression coefficient
multiplied by 10, after rounding off its value
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Minimization of bias
The allocation sequence is computer-generated (nQuery 4;
Statsols, Boston, MA, USA) using permuted blocks of dif-
ferent block sizes, with a maximum block size of 8. Alloca-
tion is stratified per center with an allocation ratio of 1:1
for each group. The process of sequence generation and
storage is managed by an independent information technol-
ogy expert not involved in patient care. Randomization is
then performed patient-by-patient using a web interface as
an integral part of the online case report form (CRF,
Additional file 3; see “Handling of data” section).
At each study site, at least two investigators are in-
volved with the study. One investigator is involved with
the intraoperative mechanical ventilation strategy and
performs the interventions defined in the protocol. A
second investigator, who is blinded to randomization,
performs postoperative visits and assessment of primary
and secondary endpoints.
Standard procedures
To avoid interference with the trial intervention, routine
elements of perioperative anesthetic care (including gen-
eral anesthesia, postoperative pain management, phy-
siotherapeutic procedures, and fluid management) are
performed according to each center’s specific expertise
and clinical routine. The following approaches are sug-
gested (not mandatory) for anesthetic management:
1. Use of inhalational isoflurane, desflurane, or sevoflurane;
intravenous propofol, remifentanil, or sufentanil; and
cisatracurium, atracurium, vecuronium, or rocuronium
as required;
2. Use of a balanced solution of prostigmine, or neostigmine
and atropine or glycopyrrolate, for reversal of muscle
relaxation, guided by neuromuscular function
monitoring;
3. Performing postoperative pain management to achieve
a visual analogue scale (VAS) pain score <3, and
regional or neuraxial analgesia should be used
whenever indicated;
4. Use of physiotherapy by early mobilization, deep
breathing exercises with and without incentive
spirometry, and stimulation of cough in the
postoperative period; (5) avoidance of hypo- and
hypervolemia;
5. Use of invasive measurement of arterial blood pressure
whenever indicated; and
6. Use of appropriate prophylactic antibiotic drugs
whenever indicated.
Data on the procedures applied will be collected in
detail and analyzed.
In addition, the study protocol stresses that routine in-
traoperative monitoring should include measurements of
noninvasive blood pressure, pulse oximetry, end-tidal
carbon dioxide fraction, and electrocardiography. Every
patient should receive at least one peripheral venous line
to allow adequate fluid resuscitation during the study
period. Nasogastric tubes, urinary bladder catheters,
and/or other intravenous catheters, as well as other,
more invasive monitoring, may be used according to
local practice and/or guidelines. Other procedures
should follow the Safe Surgery Checklist of the World
Health Organization (WHO) (www.who.int/patientsafety/
safesurgery/en/index.html).
Mechanical ventilation
Mechanical ventilation is performed with anesthesia ven-
tilators in use at each individual center participating in
the study. Patients undergo volume-controlled mechan-
ical ventilation with the lowest possible fraction of in-
spired oxygen (FiO2; ≥0.4) to maintain a peripheral
oxyhemoglobin saturation measured by pulse oximetry
(SpO2) >92%, an inspiratory-to-expiratory ratio (I:E) of
1:2, and a respiratory rate adjusted to normocapnia
(end-tidal carbon dioxide partial pressure between 35
and 45 mmHg). It is left to the discretion of the attend-
ing anesthesiologist whether to use a higher FiO2.
VT is set to 7 ml/kg (PBW). The PBW is calculated ac-
cording to a predefined formula: 50 + 0.91 × (centimeters
of height − 152.4) for men and 45.5 + 0.91 × (centimeters
of height − 152.4) for women [14, 15]. VT throughout
this protocol refers to the actual inspired VT in the ven-
tilator circuit. PEEP is set according to the randomized
intervention to 4 vs. 12 cmH2O and is modified only as
part of the rescue strategy (in case of desaturation; see
below) or at the discretion of the treating physician.
Planned and unplanned recruitment maneuvers
The RM, as part of the high-PEEP strategy, is performed
directly after induction of anesthesia, after any discon-
nection from the mechanical ventilator, every 1 h during
surgery, and before extubation, in a hemodynamically
stable situation as judged by the anesthesiologist. RMs
may also be performed as part of a rescue strategy in the
low-PEEP group. To obtain standardization among cen-
ters, RMs will be performed in volume-controlled venti-
lation mode, as shown schematically in Fig. 2, and
according to the following steps:
1. Set peak inspiratory pressure limit to 55 cmH2O.
2. Set VT to 7 ml/kg PBW and respiratory rate to ≥6
breaths/minute while PEEP is 12 cmH2O (or higher
if during rescue; see below).
3. Set I:E to 1:1.
4. Increase VT in steps of 4 ml/kg PBW until plateau
pressure reaches 40–50 cmH2O.
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5. If the maximumVT allowed by the anesthesia ventilator
is achieved and the plateau pressure is <40 cmH2O,
increase the PEEP as needed but only to a maximum of
20 cmH2O.
6. Allow the patient three breaths while maintaining
plateau pressure of 40–50 cmH2O.
7. Set respiratory rate, I:E, inspiratory pause, and VT
back to prerecruitment values while maintaining
PEEP at 12 cmH2O (or higher if during rescue).
Rescue strategies for intraoperative hypoxemia
If SpO2 ≤92% develops, increase in airway resistance,
presence of intrinsic PEEP, hemodynamic impairment,
and ventilator malfunction must be excluded before
group-specific stepwise rescue strategies can be ap-
plied (Table 2).
In patients receiving lower PEEP levels, rescue consists
primarily of an increase in FiO2, whereas elevation of
PEEP levels is restricted to more severe cases of hypox-
emia. In the higher PEEP group, the rescue strategy con-
sists primarily of increase of PEEP before FiO2 is to be
increased. At any rescue step, the treating physician may
consider reducing PEEP if SpO2 deteriorates further in
an otherwise hemodynamically stable patient.
Protocol deviation
Anesthesiologists may deviate from the ventilation
protocol at any time if concerns about patient safety
arise or upon the surgeon’s request. PEEP may be modi-
fied according to the anesthesiologist’s judgment in the
presence of any of the following clinical situations:
1. Decrease in systolic arterial pressure <90 mmHg and
unresponsive to fluids and/or vasoactive drugs
2. Need for a dosage of vasoactive drugs at the tolerance
limit
3. New arrhythmias unresponsive to the treatment
suggested by the Advanced Cardiac Life Support
Guidelines [16]
4. Blood loss requiring massive transfusion (defined as
replacement of >100% blood volume in 24 h or >50%
of blood volume in 4 h to maintain hematocrit >21%
[hemoglobin >7 mg/dl])
5. Any life-threatening surgical complication that might
benefit from changes in PEEP
Details about any protocol deviation will be prospect-
ively collected and analyzed.
Study endpoints
The primary endpoint of PROBESE is a collapsed compos-
ite of all PPCs developing within the first 5 postoperative
days. With this approach, each complication is weighted
equally. Patients who develop a least one complication are
considered as meeting the primary endpoint.
Fig. 2 Lung recruitment maneuver protocol. Ppeak Peak airway pressure, Pplat Plateau airway pressure, PEEP Positive end-expiratory pressure, Vt
Tidal volume normalized for predicted body weight, RR Respiratory rate, I:E Ratio between inspiratory and expiratory time
Table 2 Rescue strategies for intraoperative hypoxemia
Lower PEEP Higher PEEP
Step FiO2 PEEP (cmH2O) FiO2 PEEP (cmH2O)
1 0.5 4 0.4 14 (+RM)
2 0.6 4 0.4 16 (+RM)
3 0.7 4 0.4 18 (+RM)
4 0.8 4 0.5 18
5 0.9 4 0.6 18
6 1.0 4 0.7 18
7 1.0 5 0.8 18
8 1.0 6 0.9 18
9 1.0 7 (+RM) 1.0 18
10 1.0 20 (+RM)
Abbreviations: FiO2 Fraction of inspired oxygen, PEEP Positive end-expiratory
pressure, RM Recruitment maneuver
If intraoperative hypoxemia, defined as oxygen saturation ≤92%, develops,
sequences of interventions will be used according to group assignment
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PPCs are defined as follows:
1. Mild respiratory failure (partial pressure of arterial
oxygen [PaO2] <60 mmHg or SpO2 <90% breathing
at least 10 minutes of room air but responding to
supplemental oxygen of 2 L/minute, excluding
hypoventilation);
2. Moderate respiratory failure (PaO2 <60 mmHg or
SpO2 <90% breathing ≥10 minutes of room air but
responding only to supplemental oxygen >2 L/minute,
excluding hypoventilation);
3. Severe respiratory failure (need for noninvasive or
invasive mechanical ventilation, excluding
hypoventilation resulting from use of sedative agents);
4. ARDS (according to the Berlin Definition [17]);
5. Bronchospasm (newly detected expiratory wheezing
treated with bronchodilators);
6. New pulmonary infiltrates (chest x-ray demonstrating
new monolateral or bilateral infiltrate without other
clinical signs);
7. Pulmonary infection (new or progressive radiographic
infiltrate plus at least two of the following: antibiotic
treatment, tympanic temperature >38 °C, leukocytosis
or leukopenia [white blood cell count <4000 cells/mm3
or >12,000 cells/mm3], and/or purulent secretions);
8. Aspiration pneumonitis (respiratory failure after the
inhalation of regurgitated gastric contents);
9. Pleural effusion (chest x-ray demonstrating blunting
of the costophrenic angle, loss of the sharp silhouette
of the ipsilateral hemidiaphragm in upright position,
evidence of displacement of adjacent anatomical
structures, or [in supine position] a hazy opacity in
one hemithorax with preserved vascular shadows);
10.Atelectasis (lung opacification with shift of the
mediastinum, hilum, or hemidiaphragm toward the
affected area, as well as compensatory overinflation
in the adjacent nonatelectatic lung);
11.Cardiopulmonary edema (clinical signs of congestion,
including dyspnea, edema, rales, and jugular venous
distention, with chest x-ray demonstrating increase in
vascular markings and diffuse alveolar interstitial
infiltrates); and
12.Pneumothorax (air in the pleural space with no
vascular bed surrounding the visceral pleura).
Secondary clinical endpoints include the following:
1. Collapsed severe PPC composite, defined as any of
the above-mentioned adverse pulmonary events, ex-
cept mild respiratory failure;
2. Intraoperative adverse events (AEs), such as hypoxemia
(defined as SpO2 ≤92%), hypotension (defined as systolic
blood pressure <90 mmHg), and bradycardia (defined
as heart rate <50 beats/minute);
3. Unexpected need for intensive care unit (ICU) admission
or ICU readmission;
4. Hospital-free days at follow-up day 90;
5. Postoperative wound healing; and
6. Postoperative extrapulmonary complications (PEPCs).
PEPCs include systemic inflammatory response syn-
drome, sepsis, severe sepsis, and septic shock (all ac-
cording to consensus criteria [18]); extrapulmonary
infection (wound infection or any other infection); coma
(Glasgow Coma Scale score <8 in the absence of thera-
peutic coma or sedation); acute myocardial infarction
(according to universal definition of myocardial infarc-
tion [19]); acute renal failure (according to the risk,
injury, failure, loss, end-stage kidney disease [RIFLE]
classification system [20]); disseminated intravascular
coagulation (DIC) (according to the International
Society of Thrombosis and Hemostasis diagnostic scor-
ing system for DIC [21]); gastrointestinal failure (GIF)
(defined according to the GIF score [22]); and hepatic
failure (defined as the ratio of total bilirubin on postop-
erative day 5 to postoperative day 1 >1.7 and ratio of
international normalized ratio [INR] on postoperative
day 5 to postoperative day 1 >1.0, or new presence of
hepatic encephalopathy and coagulopathy [INR >1.5]
within 8 weeks after initial signs of liver injury [e.g., jaun-
dice] without evidence of chronic liver disease) (adapted
from Du et al. [23] and Wlodzimirow et al. [24]).
At the discretion of participating centers, blood and
urine samples are collected preoperatively as well as dir-
ectly postoperatively and on postoperative day 5. Sam-
ples will be analyzed centrally for systemic markers of
inflammation and coagulation (including but not limited
to interleukins 6 and 8, thrombin-antithrombin, protein
C, and plasminogen activator inhibitor-1) as well as sys-
temic markers of injury to the lungs (including but not
limited to plasma E-cadherin, soluble receptor for ad-
vanced glycation end products, and surfactant proteins
A and D) and to distal organs, including renal injury (in-
cluding but not limited to plasma/urine neutrophil gela-
tinase-associated lipocalin and cystatin C). The standard
operating procedure for collecting and processing bio-
markers in plasma and urine is available in the online sup-
plement (Additional files 4 and 5, respectively).
Study visits and data collection
Patients are visited preoperatively, intraoperatively,
daily between postoperative days 1 and 5, and at dis-
charge. On postoperative day 90, patients are con-
tacted by phone (Fig. 3). A complete participant time
line, including all variables as well as interventions, is
available in Additional files 1 and 2.
During the preoperative visit, eligible patients meeting
none of the exclusion criteria are asked by physicians to
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provide written informed consent. (Model consent form
and information to study patients). Baseline variables are
collected, including sex; age; height; weight; BMI; waist/
hip ratio according to WHO guidelines; physical status
according to the American Society of Anesthesiologists;
functional status according to Cumulated Ambulation
Score [25]; cardiovascular status (heart failure according
to the New York Heart Association classification, coron-
ary heart disease according to Canadian Cardiovascular
Society, atrial flutter/fibrillation, arterial hypertension);
pulmonary status (COPD, including steroids and/or in-
halation therapy use, respiratory infection within the last
month, use of noninvasive ventilatory support); history
of OSA, including apnea-hypopnea index or STOP-Bang
score (snoring, tired, observed stopped breathing or
choking/gasping, pressure, body mass index >35 kg/m2,
age >50 years, large neck size, and male sex) [26] in
patients without diagnosis of OSA); metabolic status
(diabetes mellitus, including data on treatment); history
of active cancer; smoking status; alcohol status; gastro-
esophageal reflux; oral medication (e.g., use of antibi-
otics, statins, aspirin); preoperative organ function (SpO2
in beach chair position breathing room air; if possible,
SpO2 in supine position breathing room air; if possible,
so-called oxygen stress test, with this measurement left
to the discretion of each center); respiratory rate; heart
rate; mean arterial pressure; body temperature; airway
secretion, including data on purulence, VAS score
(1–10) for dyspnea, chest pain, and abdominal rest; and
incident pain. Preoperative nonmandatory measure-
ments include spirometry (forced ventilatory capacity,
forced expiratory volume in 1 second), chest x-ray
(assessed for infiltrates, pleural effusion, atelectasis,
pneumothorax, and cardiopulmonary edema), and routine
STUDY PERIOD
Enrolment Allocation / Intervention Post-Intervention Close-out
TIMEPOINT** Preoperative 
visit
Before 
anesthesia
During 
surgery 
(every 
hour)
End of 
surgery
POD 
1
POD 
2
POD 
3
POD 
4
POD 
5
Hospital 
discharge
POD 90 
(phone 
call)
ENROLMENT
Eligibility screen X
Informed consent X
Demographic data X
History of previous 
disease X
Allocation X
INTERVENTION
High PEEP with 
RM X
Low PEEP without 
RM X
Respiratory / 
hemodynamic 
variables
X
Adverse events X
Anesthesia / 
Surgery variables X
Need for Rescue / 
protocol deviation X
ASSESSMENTS
Recovery status X X X X X X
SpO2 in room air X X X X X X X
Spirometry / Chest 
X-ray (facultative) X X X X X X X
Pulmonary 
complications X X X X X X
Extrapulmonary 
complications X X X X X X
Adverse events X X X X X X
Blood sampling 
(special markers, 
facultative)
X X X
POD of discharge X
Hospital free days 
on POD 90 X
Fig. 3 Schedule of enrollment, interventions, and assessments. POD Postoperative day, PEEP Positive end-expiratory airway pressure, RM Recruitment
maneuver, SpO2 Peripheral oxyhemoglobin saturation measured by pulse oximetry
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laboratory tests (including hemoglobin, white blood cell
count, platelet count, prothrombin time, partial thrombo-
plastin time, creatinine, blood urea nitrogen, alanine ami-
notransferase, aspartate amino transferase, bilirubin).
During the intraoperative visit, both surgery- and
anesthesia-related data are recorded, including duration
of surgery (from incision to closure), transfusion of
blood products within 6 h before surgery, priority and
type of surgery, wound classification, patient positioning
during operation, duration of anesthesia (from intub-
ation to extubation or exit from operating room if on
mechanical ventilation), anesthetic procedure details,
drugs and fluids administered during anesthesia (e.g., an-
esthetics, vasoactive drugs, transfusion). Ventilator set-
tings, hemodynamics, need for rescue strategy, and AEs
are recorded at anesthesia induction and hourly there-
after (in the higher PEEP group, before performing the
RM) as well as during the plateau phase of the RM.
Clinical data, including actual organ function and the
presence of PPCs and PEPCs, are scored during postop-
erative visits on a daily basis. Nonmandatory measures
include chest x-ray, spirometry, and routine laboratory
tests. Patients will be visited until discharge. On postop-
erative day 90, the sum of hospital-free days is recorded.
Day 90 is defined as the last day of follow-up; accord-
ingly, patients still admitted to the hospital will be last
visited on that day.
Study dropouts
Because participation in the trial is voluntary, a subject
has the right to withdraw consent to participate in the
study at any time for any reason without any conse-
quences for further medical treatment. Furthermore, in-
vestigators have the right to terminate participation of
any subject at any time if the investigator deems it in the
participant’s best interest. The reasons and circum-
stances for study discontinuation will be documented in
the CRF. Primarily, all data will be analyzed according to
the intention-to-treat (ITT) principle. Secondarily, data
will be analyzed as per protocol.
Handling of data
Patient data are collected in pseudonymous form using a
patient identification number of six digits. The first three
digits correspond to the site identifier, and the remaining
three digits correspond to the patient inclusion number
at the respective site. Study data are collected and man-
aged using Research Electronic Data Capture (REDCap™;
a web-based system used during PROBESE as electronic
case report form) electronic data capture tools hosted at
the Coordinating Center for Clinical Trials of the
University of Dresden, Germany [27]. REDCap is a Se-
cure Sockets Layer (SSL)-encrypted, password-protected,
web-based application designed to support data capture
for research studies. Full access to the final trial dataset
will be granted to selected investigators only (MGdA,
TB, and JSc). If a substudy is approved by the steering
committee, access to data related only to the substudy
will be granted to the respective principal investigator.
Sample size calculations
Sample size calculation was based on our primary hypoth-
esis that, in obese patients ventilated intraoperatively with
protective low VT, high PEEP leads to lower incidence of
PPCs than lower PEEP. Effect sizes were derived from
data collected during the ARISCAT study [13] and a
single-center, relatively small study in which researchers
reported the effects of intraoperative higher PEEP and
RMs on the incidence of postoperative desaturation, chest
infection, and bronchospasm in obese patients who
underwent laparoscopic bariatric surgery [28].
Prior to the start of the study, these calculations had
indicated that 356 patients would be required per group,
assuming a two-sided significance level of 0.05 (α) and a
power of 80%, to detect the expected difference in PPCs
between the higher-PEEP group of 30% and the lower-
PEEP group of 40% (risk ratio of 0.75). However, the
sample size was reestimated after data of the first 618
patients revealed that the overall incidence of the col-
lapsed composite outcome was 20% and, thus, lower
than initially expected. Also, the adjustment of the sam-
ple size took into account the need for interim analyses
for efficacy and futility at 50%, 75%, and 100% of the
total number of patients, for which a nonbinding group
sequential design with γ spending functions (γ = −4 for
each of α and β) was used. In total, 1912 patients will be
included in the analysis. Assuming a dropout rate of 5%,
2013 patients will be enrolled. Table 3 shows the α and
β spent over the trial, z-statistic boundaries for effi-
cacy and futility, and boundary-crossing probabilities
under the alternative hypothesis (H1). The corre-
sponding P value boundaries for efficacy and futility
at the first, second, and final looks, respectively, are
P ≤ 0.006, P ≤ 0.015, and P ≤ 0.044, as well as P > 0.82,
P > 0.35, and P > 0.044, respectively. Figure 4 displays
the z-statistic boundaries for efficacy/harm and futility
as a function of accrued sample size. East 6.0 interim
monitoring software (Cytel Inc., Cambridge, MA,
USA) was used for sample size calculations.
To foster the study and increase the interest of prac-
ticing physicians, the steering committee will apply for en-
dorsement of national and international professional
societies. The following societies have already given en-
dorsement to the trial: the European Society of Anaesthe-
siology, the European Society for Perioperative Care of the
Obese Patient, the German Society of Anesthesiology and
Intensive Care Medicine, and the Italian Society of
Anesthesiology and Reanimation.
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Statistical analysis
Exploratory analysis will include mean and SD for nor-
mally distributed variables. Non-normally distributed
variables will be expressed by their medians and IQRs,
and categorical variables will be expressed as count
(percent). Parametric or nonparametric tests will be used
as appropriate. Categorical variables will be compared
with chi-square tests, Fisher’s exact test, or as relative
risk, if appropriate. Statistical uncertainty will be
expressed by 95% CIs.
Preoperative (baseline) data will be tested for any
imbalance. If imbalances are detected (despite 1:1
randomization of a relatively large cohort), those fac-
tors will be corrected for using a multiple logistic re-
gression model.
The primary endpoint, namely occurrence of any PPC
(collapsed composite endpoint) within the first 5 postop-
erative days, will be presented as total percentage per
group and analyzed as continuous data. Primary and sec-
ondary outcome variables describing time to event will
be analyzed using a proportional hazards model adjusted
for possible baseline imbalances. A linear mixed model
with two factors (study group and time) will be used to
analyze variables repetitively measured over time.
In case of loss to follow-up or study dropout, those
cases will be reported, and ITT as well as per-protocol
analyses will be performed. For ITT analysis, data will be
processed for all patients in the groups to which they
were randomized. The per-protocol analysis will be con-
ducted to assess the primary outcome in cases where
there is a considerable proportion of patients who do
not receive their randomized intervention or are lost to
follow-up. Patients discharged earlier than postoperative
day 5 are considered as not experiencing any PPC or
PEPC during the out-of-hospital days. In this regard,
missing data will be handled by means of the last obser-
vation carried forward method.
Given that laparoscopic surgery is common in obese
patients, we anticipate that a subgroup analysis of pri-
mary and secondary endpoints will be conducted for this
type of surgery as well. A further subgroup analysis of
patients with obesity class III according to the WHO
definition (i.e., BMI ≥40 kg/m2) will be performed. Given
the importance of driving pressure to determine PPCs
[29, 30], a subgroup analysis taking into account cutoff
values and changes in PEEP will be conducted.
Possibility and policy for substudies
Participating centers are allowed to conduct substudies,
provided that (1) no interference with the primary
protocol occurs; (2) approval by the local institutional
review board is obtained; and (3) the steering committee
accepts the proposal according to its originality, feasibil-
ity, and importance. Currently, substudies with electrical
impedance tomography, spirometry, respiratory system
mechanics, and preoperative oxygen stress test are under
evaluation. Publication of substudies, in any form, is
strictly forbidden until the results of the primary study
have been published.
Trial organization
The trial is managed by a team consisting of the chief inves-
tigator (MGdA), the trial coordinator (TB), the statisticians
(JSc, GM), the informatics technician responsible for the
web-based electronic data capture system (Marko Kaeppler),
and the monitors (Luigi Vivona, Alice Bergamaschi). A
steering committee contributed to the design and revision
Table 3 Z-statistic boundaries and boundary-crossing probabilities
Look Information
fraction
N Cumulative
α spent
Cumulative
β spent
Z-
efficacy
Z-
futility
Boundary-crossing probabilities under H1
Efficacy Futility
1 0.5 956 0.006 0.024 ≥2.75 <0.225 0.234 0.024
2 0.75 1434 0.018 0.071 ≥2.432 <0.929 0.296 0.047
3 1 1912 0.05 0.2 ≥2.012 <2.012 0.271 0.129
Look Interim analysis, N Number of patients, H1 Hypothesis 1 (group difference exists)
Values were calculated using power = 0.80, α = 0.05, γ spending functions (γ = −4), and expected incidence of postoperative pulmonary complications of 20% (p1)
and 15% (p2) in the lower and higher positive end-expiratory pressure groups, respectively
Fig. 4 Effect size (Z) according to enrollment of patients in the
PRotective Ventilation with Higher versus Lower PEEP during General
Anesthesia for Surgery in OBESE Patients (PROBESE) trial
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of the study and will be responsible for interpretation of data
and compilation of a resulting manuscript.
Patient data and safety are closely monitored by a
DSMB, which is composed of a chairperson (Daniel
Sessler) and four other members (Jennifer Hunter,
Jeanine Wiener-Kronish, Jean-Louis Vincent, and An-
dreas Hoeft). All AEs entered into the electronic CRF
within prespecified time frames, including severe AEs
and suspected unexpected severe adverse reactions, are
monitored by an international AE manager (ASN), who
provides the DSMB with reports for review. The DSMB
further monitors the overall status of the trial (e.g., pro-
gress of patient enrollment, general adherence to proto-
col, and completeness of data entry). Monitoring visits
will be conducted as deemed necessary by the DSMB.
National coordinators are responsible for administration
and communication with local principal investigators, as
well as for assistance during trial management and
data collection. When submitting the report on the
results of the trial for possible publication, sites will
be eligible for one collaborative coauthorship plus a
further coauthorship for every 12 treated patients
with complete datasets.
Discussion
Despite being lifesaving, mechanical ventilation has the
potential to aggravate or even initiate lung injury. In pa-
tients with previously injured lungs, especially those with
ARDS, mechanical ventilation with low VT [31] and
driving pressures [32] has been shown to decrease mor-
tality. Furthermore, in more severe ARDS, high PEEP
improves survival [33]. Such effects have been attributed
to avoidance of tidal overdistention as well as cyclic col-
lapse and reopening of lung units, which may trigger the
inflammatory lung response [34]. Interestingly, low VT
with low to moderate PEEP levels has been also reported
to facilitate weaning [35] and reduce pulmonary compli-
cations [36] in critically ill patients without lung injury.
However, the value of protective ventilation in the ab-
sence of lung injury has been challenged. In pigs with
noninjured lungs, VT as high as 27 ml/kg was not associ-
ated with relevant degrees of lung damage [37]. Such an
observation might be explained by the fact that, within a
certain range, mechanical ventilation does not injure
lungs if a previous insult (first hit), such as inflamma-
tion, ischemia-reperfusion injury, or factors impairing
the homogeneity of ventilation [38], are not present.
Surgery itself can trigger a systemic inflammatory re-
sponse [39], which may prime the lungs for possible
harmful effects of mechanical ventilation. In fact, pro-
tective intraoperative mechanical ventilation with low
VT and PEEP is able to prevent postoperative respiratory
failure in patients undergoing abdominal or thoracic
surgery, and those who develop this adverse pulmonary
event not only have longer stays in the hospital but
also a significantly higher risk of death [2]. However,
though the role of intraoperative low VT [6] and low
driving pressure [29, 30] to decrease the risk of PPCs
has been defined, the role of PEEP is more controver-
sial [4, 7, 40, 41].
The decision to address the obese patient population
undergoing surgery is based on several aspects. The pro-
portion of obese patients undergoing surgery is higher
than in the general population [42]. Treatment of these
patients is usually challenging because their needs in
terms of perioperative care differ from those of nonob-
ese patients and are often unmet. For example, the dele-
terious effects of anesthesia on the respiratory system of
obese patients are exacerbated when compared with
nonobese patients. The known decrease in end-
expiratory lung volume following induction of general
anesthesia is striking in obese patients, mainly because
of formation of lung atelectasis, which may impair gas
exchange [43]. Previous studies addressed the effects of
intraoperative mechanical ventilation strategies aimed at
reverting the formation of atelectasis during general
anesthesia in obese patients. Respiratory strategies that
increase the pressure of the airways during induction of
anesthesia, such as the application of noninvasive venti-
lation [44], use of PEEP with [45] or without RMs [46],
or a combination of all of these [47], seem to be useful
for improving the respiratory function of obese patients
in the pre- and intraoperative periods [48]. Nevertheless,
their effects seem to be short-lived in the postoperative
period [49, 50]. To our knowledge, the impact of such
strategies on clinically relevant outcome endpoints, such
as adverse pulmonary events, has not previously been
addressed. Therefore, we believe PROBESE is the first
large, international, multicenter randomized controlled
trial addressing the effects of PEEP during protective
low VT on postoperative outcome.
We opted for testing the impact of two ventilation
strategies at the same low VT but mainly differing in the
level of PEEP. The decision to use a PEEP value of 4
cmH2O in the low-PEEP group derives mainly from re-
ports on the practice of intraoperative mechanical venti-
lation in obese patients [11, 51], but it also takes into
account aspects regarding patient safety. In fact, use of
PEEP of 0 cmH2O during anesthesia in morbidly obese
patients is still common practice and is usually compen-
sated for by means of proportionally high VT values [52].
The level of PEEP in the high-PEEP group has been in-
tensely debated by the steering committee of the trial.
The decision to use a PEEP of 12 cmH2O was based on
reports of several small clinical studies showing that such
a level of PEEP is able to preserve the end-expiratory lung
volume after induction of anesthesia [46, 53] and to avoid
development of significant atelectasis when preceded by
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RMs [45]. Theoretically, PEEP values >12 cmH2O might
be even more effective to avoid progressive derecruitment
of lungs, but they could also result in more severe impair-
ment of hemodynamics [54, 55]. In fact, a previous trial by
our group with nonobese patients undergoing open ab-
dominal surgery showed that high PEEP levels are more
frequently associated with intraoperative hypotension that
in turn requires more fluids and support with vasoactive
drugs [7]. We also decided not to use an individual titra-
tion of PEEP for two reasons. First, even a PEEP titrated
to a respiratory mechanical target, such as the elastance of
the respiratory system, represents a compromise in terms
of regional overdistention and collapsing-reopening of
lung units and does not fully prevent atelectasis formation.
Second, the setting of PEEP shall be pragmatic (i.e., prac-
ticable for anesthetists worldwide) while keeping the
physiological rationale. The RM is based on a stepwise in-
crease of VT and PEEP, which allows opening of lung units
without interruption of mechanical ventilation [40] and
ensures standardization across different centers [7].
Furthermore, because the maneuver was designed for
volume-controlled ventilation, it can be performed with
practically all anesthesia ventilators. During RMs, the tar-
get airway pressure in the range of 40–50 cmH2O was
based on previous functional studies in obese patients.
Also, the inspiratory time of approximately 5 seconds was
chosen to allow enough pressure versus time product to
open atelectatic lung units [56]. We opted for recruiting
lungs not only after intubation but also every hour there-
after in order to revert possible progressive derecruitment
at PEEP of 12 cmH2O. For both the lower- and higher-
PEEP groups, rescue protocols for the progression of in-
traoperative hypoxemia were defined to protect patients
while allowing a standardized approach that minimizes
interference with the respective interventions. Import-
antly, deviations from the protocol, even rescue because
of hypoxemia, are explicitly allowed, provided this is in
the best interest of the patient.
It is worth noting that recommendations have been
made also with regard to different phases and aspects of
the anesthetic procedure, including monitoring, choice
of anesthetic agents, muscle paralysis and its reversal,
intravascular volume loading and maintenance, postop-
erative analgesia target, and respiratory management at
induction and emergence of anesthesia (e.g., use of con-
tinuous or noninvasive positive pressure and positioning).
However, PROBESE is a pragmatic study, and influence
on local practice of respective sites is being kept to a mini-
mum, focusing on factors that are more directly related to
the hypothesis being investigated.
Besides postoperative respiratory failure, several other
adverse pulmonary events seem to add to the odds of
mortality in the surgical population. In-hospital length
of stay and mortality increase with the number of single
pulmonary AEs in the postoperative period [1]. For this
reason, in the PROBESE trial, we opted for a binary col-
lapsed composite of single adverse pulmonary events as
a primary endpoint, despite the fact that single events
may differ in terms of severity. Therefore, the use of
PPCs as a primary endpoint in the PROBESE trial not
only has clinical relevance for the practicing anesthetist
but also increases the study power because of summa-
tion of the incidence of single AEs. In spite of this, the
study analysis will address not only the composite itself
but also the incidence of each element separately, as well
as a secondary composite that excludes mild respiratory
failure. Furthermore, given the importance of minimally
invasive surgical techniques in the obese population, we
will conduct a separate analysis of the primary endpoint
in patients undergoing laparoscopic surgery, as well as
of patients with obesity class III of the WHO (BMI
≥40 kg/m2).
Not only the respiratory system but also other organ
systems may be impaired in the postoperative period in
obese patients. Thus, the analysis will also address the im-
pact of intraoperative mechanical ventilation on single or-
gans and a collapsed composite of nonpulmonary AEs,
namely the PEPCs. In addition, further relevant outcome
measures that might be related to PPCs and PEPCs, espe-
cially the length of hospital stay, will be addressed. This
outcome variable not only is a measure of morbidity but
has also direct impact on related health costs. Because we
anticipate that, during surgery, both the lower- and the
higher-PEEP groups will experience impacts on intraoper-
ative oxygenation, respiratory system mechanics, and ar-
terial blood pressure, intraoperative respiratory function
and hemodynamic variables will also be evaluated.
Much attention has been paid to safety in the PROB-
ESE trial. Accordingly, data and patient safety during the
PROBESE trial is closely monitored by a DSMB whose
members have been chosen for their expertise in clinical
research, as well as by a serious AE/AE manager. The
web-based approach for research electronic data capture
(REDCap™) will be used for building the database within
a secure system and allowing access to the electronic
CRF as well as randomization of patients into groups
within one single platform from all participating sites
across the world.
In summary, PROBESE is the first multicenter, inter-
national, adequately powered randomized controlled
trial that compares the effects of two different levels of
intraoperative PEEP during protective low VT on PPCs
in obese patients. The results of the PROBESE trial will
support anesthesiologists in their decision to set PEEP
during general anesthesia for surgery in obese patients.
Trial status
The PROBESE trial is currently recruiting patients.
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Appendix 1
Table 4 PROBESE investigators
Site ID Site name Collaborator(s) Email address(es)
001 Department of Anesthesiology and Intensive
Care Medicine, Pulmonary Engineering Group,
University Hospital Dresden, Germany
Andreas Güldner
Robert Huhle
Christopher Uhlig
Luigi Vivona
Alice Bergamaschi
andreas.güldner@uniklinikum-dresden.de
robert.huhle@tu-dresden.de
christopher.uhlig@uniklinikum-dresden.de
vivonag@tiscali.it
alice_bergamaschi@libero.it
002 Department of Anesthesiology, University of
Aachen, Germany
Rossaint, Rolf
Stevanovic, Ana
rrossaint@ukaachen.de
astevanovic@ukaachen.de
003 Department of Anesthesiology CLIPS Clinical
Trials – Patient-centered Studies, University
Hospital Düsseldorf, Germany
Treschan, Tanja
Maximilian Schaefer
Kienbaum, Peter
tanja.treschan@med.uni-duesseldorf.de
maximilian.schaefer@med.uni-duesseldorf.de
peter.kienbaum@med.uni-duesseldorf.de
004 Department of Anesthesiology, University
Medical Center Mainz, Germany
Laufenberg-Feldmann, Rita rita.laufenberg@unimedizin-mainz.de
005 Department of Anesthesiology, Intensive Care
and Pain Medicine, University Clinic
Knappschaftskrankenhaus Bochum, Germany
Bergmann, Lars
Ebner, Felix
Robitzky, Luisa
Mölders, Patrick
Unterberg, Matthias
lars.bergmann@kk-bochum.de
felix.ebner@kk-bochum.de
luisa.robitzky@gmail.com
patrick.moelders@kk-bochum.de
matthias.unterberg@kk-bochum.de
006 Department of Anesthesiology, University
Hospital Heidelberg, Germany
Busch, Cornelius cornelius.busch@med.uni-heidelberg.de
007 Department of Anesthesiology, Marienhospital
Wesel, Germany
Achilles, Marc marc.achilles@prohomine.de
008 Department of Anesthesiology and Intensive
Care Medicine, Marienstift Friesoythe, Germany
Menzen, Angelika
Freesemann, Harbert
dr.menzen@marienstift-friesoythe.de
dr.freesemann@smhf.de
009 Department of Anesthesiology and Intensive
Care Medicine, University Hospital Bonn, Germany
Putensen, Christian putensen@uni-bonn.de
011 Serviço de Anestesiologia, Centro Hospitalar
do Porto, Portugal
Machado, Humberto
Cavaleiro, Carla
Ferreira, Cristina
Pinho, Daniela
Carvalho, Marta
Pinho, Sílvia
Soares, Maria
director.anestesia@hgsa.min-saude.pt
cscavaleiro@gmail.com
crispintoferreira@gamil.com
daniepinho@gmail.com
marta.monteiro.carvalho@gmail.com
silviaabpinho@gmail.com
mariapereirasoares@gmail.com
012 Serviço de Anestesiologia, Centro Hospitalar Entre
o Douro e Vouga, Santa Maria da Feira, Portugal
Castro, Diogo Sousa diogosousacastro@hotmail.com
013 Serviço de Anestesiologia, Centro Hospitalar São
João, Porto, Portugal
Abelha, Fernando fernando.abelha@gmail.com
014 Serviço de Anestesiologia, Hospital Pedro Hispano,
Matosinhos, Portugal
Rabico, Rui rrabico@gmail.com
021 Department of Anesthesiology, Montefiore Medical
Center Bronx, New York, NY, USA
Delphin, Ellise edelphin@montefiore.org
022 Department of Anesthesiology, Mayo Clinic,
Rochester, MN, USA
Sprung, Juraj
Weingarten, Toby N.
Kellogg, Todd A.
Martin, Yvette N.
McKenzie, Travis J
sprung.juraj@mayo.edu
weingarten.toby@mayo.edu
kellogg.todd@mayo.edu
martin.yvette@mayo.edu
mckenzie.travis@mayo.edu
023 Department of Anesthesiology, Mayo Clinic,
Jacksonville, FL, USA
Brull, Sorin J.
Renew, J. Ross
brull.sorin@mayo.edu
renew.j@mayo.edu
024 Department of Anesthesiology, Mayo Clinic,
Phoenix, AZ, USA
Ramakrishna, Harish ramakrishna.harish@mayo.edu
025 Department of Anesthesiology, University of
Colorado SOM, Aurora, CO, USA
Fernandez-Bustamante, Ana ana.fernandez-bustamante@ucdenver.edu
026 Department of Anesthesiology, Tufts Medical
Center, Boston, MA, USA
Balonov, Konstantin kbalonov@tuftsmedicalcenter.org
027 Department of Anesthesiology, University of
Mississippi, Jackson, MS, USA
Baig, Harris R. hbaig@umc.edu
Bluth et al. Trials  (2017) 18:202 Page 12 of 22
Table 4 PROBESE investigators (Continued)
028 Department of Anesthesiology, University of
Chicago, Chicago, IL, USA
Kacha, Aalok akacha@dacc.uchicago.edu
031 Department of Anesthesiology, Pontificia
Universidad Católica de Chile, Santiago de
Chile, Chile
Pedemonte, Juan C.
Altermatt, Fernando
Corvetto, Marcia A.
Paredes, Sebastian
Carmona, Javiera
Rolle, Augusto
jcpedemo@gmail.com
falterma@med.puc.cl
marciacorvetto@gmail.com
sparedese@gmail.com
javiera.carmona.b@gmail.com
arollep@gmail.com
041 Department of Intensive Care, Academic Medical
Center, University of Amsterdam, The Netherlands
Bos, Elke
Beurskens, Charlotte
e.m.bos@amc.uva.nl
c.j.beurskens@amc.uva.nl
042 Department of Anesthesiology, Leiden University
Medical Center, Leiden, The Netherlands
Veering, B b.t.h.veering@lumc.nl
043 Department of Anesthesiology, Westfriesgasthuis,
Hoorn, The Netherlands
Zonneveldt, Harry h.zonneveldt@westfriesgasthuis.nl
044 Department of Anesthesiology, VU Medical
Center, Amsterdam, The Netherlands
Boer, Christa m.w.hollmann@amc.uva.nl
045 Department of Anesthesiology, Onze Lieve
Vrouwen Gasthuis (OLVG), Amsterdam,
The Netherlands
Godfried, Marc
Thiel, Bram
m.b.godfried@olvg.nl
b.thiel@olvg.nl
051 Department of Anesthesiology and General
Intensive Care, Medical University of Vienna,
Austria
Kabon, Barbara
Reiterer, Christian
barbara.kabon@meduniwien.ac.at
christian.reiterer@meduniwien.ac.at
061 Department of Anesthesiology, Hospital Universitari
Germans Trias i Pujol, Badalona, Spain
Canet, Jaume
Tolós, Raquel
Sendra, Mar
González, Miriam
Gómez, Noemí
jcanet.germanstrias@gencat.cat
rakeltp@yahoo.es
marsendra@gmail.com
miriamgn@hotmail.com
noe6gl@hotmail.com
062 Department of Anesthesiology and Critical Care,
Hospital Clinico Universitario de Valencia, Spain
Ferrando, Carlos
Tania Socorro
Ana Izquierdo
Marina Soro
cafeoranestesia@gmail.com
austania@gmail.com
anaizpa@gmail.com
soromarina@gmail.com
063 Department of Anesthesiology, Critical Care
and Pain Relief, Consorcio Hospital General
Universitario de Valencia, Spain
Granell Gil, Manuel
Hernández Cádiz, María José
Biosca Pérez, Elena
mgranellg@hotmail.com
mj.herca@hotmail.com
ebipe@hotmail.com
064 Department of Anesthesiology and Surgical
Critical Care, Hospital Universitario La Paz,
Madrid, Spain
Suarez-de-la-Rica, Alejandro
Lopez-Martinez, Mercedes
Huercio, Iván
Maseda, Emilio
Yagüe, Julio
alejandro.suarez.delarica@gmail.com
mercelopezmartinez@yahoo.es
ivanhuercio@gmail.com
emilio.maseda@gmail.com
juyaru@gmail.com
065 Department of Anesthesiology, Hospital Universitari
Mútua de Terrassa, Spain
Cebrian Moreno, Alba a.cebrian.moreno@gmail.com
066 Department of Anesthesiology, Hospital Clinic
de Barcelona, Spain
Rivas, Eva
Lopez-Baamonde, Manuel
erivas@clinic.ub.es
lopez10@clinic.cat
071 Depts. of Anesthesiology, 1King Abdullah
Medical City, Makkah, Saudi Arabia & 2Assiut
University- EGYPT & 3Mansoura University- EGYPT.
1,2 Elgendy, Hamed
1,3Sayedalahl,Mohamed
helgendy70@gmail.com
al-ahl.m@kamc.med.sa
072 Department of Anesthesiology, King Abdulaziz
National Guard Medical City, Riyadh, Saudi Arabia
Sibai, Abdul Razak sibaiab@ngha.med.sa
081 Department of Anaesthesiology, Istanbul Medical
Faculty, Istanbul University, Istanbul, Turkey
Yavru, Aysen
Sivrikoz, Nukhet
Karadeniz, Meltem
aysenyg@gmail.com
ntsz06@gmail.com
mskaradeniz@gmail.com
082 Department of Anesthesiology and Reanimation,
Marmara University School of Medicine,
Istanbul, Turkey
Corman Dincer, Pelin
Ayanoglu, Hilmi Omer
Tore Altun, Gulbin
Kavas, Ayse Duygu
pelincorman@yahoo.com
ayanoglu@mamara.edu.tr
dr_gulbin@yahoo.com
adkavas@hotmail.com
083 Department of Anesthesiology and Reanimation,
Akdeniz University Hospital, Antalya, Turkey
Dinc, Bora drboradinc@gmail.com
084 Department of Anesthesiology and Reanimation,
Dokuz Eylül University of Medicine, Izmir, Turkey
Kuvaki, Bahar
Ozbilgin, Sule
bkuvaki@deu.edu.tr
ozbilginsule@gmail.com
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085 Department of Anesthesiology and Reanimation,
Fatih Sultan Mehmet Educational and Research
Hospital, Istanbul, Turkey
Erdogan, Dilek
Koksal, Ceren
Abitagaglu, Suheyla
dilekerdoganari@gmail.com
ceren_hazer@yahoo.com
suheylaatay81@gmail.com
091 Department of Anaesthesiological, Surgical and
Emergency Sciences, Second University of
Naples, Italy
Aurilio, Caterina
Sansone, Pasquale
Pace, Caterina Maria
Donatiello, Valerio
Mattera, Silvana
Palange, Nazareno
Di Colandrea, Salvatore
caterina.aurilio@unina2.it
pasquale.sansone@unina2.it
caterina.pace@libero.it
valerio.donatiello@gmail.com
silvanamattera@gmail.com
nazareno.palange@gmail.com
di.colandrea@libero.it
092 Department of Morphology, Surgery and
Experimental Medicine, Ospedale Sant’ Anna,
Ferrara, Italy
Spadaro, Savino
Volta, Carlo Alberto
Ragazzi, Riccardo
Ciardo, Stefano
Gobbi, Luca
savinospadaro@gmail.com
vlc@unife.it
rgc@unife.it
stefano.ciardo@student.unife.it
lucagobbi1988@gmail.com
093 Department of Environment, Health and Safety,
University of Insubria, Varese, Italy
Severgnini, Paolo
Bacuzzi, Alessandro
Brugnoni, Elisa
paolo.severgnini@uninsubria.it
alessandro.bacuzzi@gmail.com
elisa.brugnoni@gmail.com
094 Dept. of Surgical Sciences and Integrated
Diagnostics, IRCCS AOU San Martino, IST,
University of Genoa, Italy
Gratarola, Angelo
Micalizzi, Camilla
Simonassi, Francesca
Malerbi, Patrizia
a.gratarola@gmail.com
camilla.micalizzi@gmail.com
fra.simonassi@libero.it
patrizia.malerbi@hsanmartino.it
095 Department of Anesthesiology and Reanimation,
Ospedale U. Parini, AUSL della Valle d’ Aosta, Italy
Carboni, Adrea acarboni@ausl.vda.it
101 Department of Anesthesiology, Pharmacology &
Intensive Care, University Hospital Geneva,
Switzerland
Licker, Marc-Joseph marc-joseph.licker@hcuge.ch
102 Institute for Anesthesia and Intensive Care
Medicine, Kantonsspital Frauenfeld, Switzerland
Dullenkopf, Alexander alexander.dullenkopf@stgag.ch
103 Department of Anesthesia, Surgical Intensive
Care, Prehospital Emergency Medicine and
Pain Therapy, University Hospital Basel,
Switzerland
Goettel, Nicolai nicolai.goettel@usb.ch
111 University Department of Anesthesiology,
Resuscitation and Intensive Care, University
Hospital Sveti Duh, Zagreb, Croatia
Nesek Adam, Visnja
Karaman Ilić, Maja
visnja.nesek@hotmail.com
majakilic@gmail.com
112 Department of Anesthesiology, Resuscitation
and Intensive Care, Clinical Hospital Dubrava,
Zagreb, Croatia
Klaric, Vlasta
Vitkovic, Bibiana
Milic, Morena
Miro, Zupcic
vllastica@gmail.com
bibianavit@hotmail.com
morena.milic@gmail.com
miro_zupcic@yahoo.com
121 Department of Anesthesiology, Ghent University
Hospital, Belgium
De Baerdemaeker, Luc
De Hert, Stefan
Heyse, Bjorn
Van Limmen, Jurgen
Van Nieuwenhove, Yves
luc.debaerdemaeker@ugent.be
stefan.dehert@ugent.be
bjorn.heyse@ugent.be
jurgen.vanlimmen@ugent.be
yves.vannieuwenhove@ugent.be
123 Department of Anesthesiology, UH Antwerpen,
Belgium
Mertens, Els els.mertens@uza.be
124 Department of Anesthesiology, UZ Leuven,
Belgium
Neyrinck, Arne arne.neyrinck@uzleuven.be
125 Department of Anaesthesiology, Intensive care
and Emergency, AZ Sint Jan Brugge, Bruges, Belgium
Mulier, Jan jan.mulier@azsintjan.be
126 Department of Anesthesiology, Cliniques
Universitaires St Luc, Belgium
Kahn, David david.kahn@uclouvain.be
131 Department of Anesthesiology, Ponderas
Hospital, Bucharest, Romania
Godoroja, Daniela danielagodoroja@yahoo.com
141 Department of Intensive Care, St James’s
University Hospital, Dublin, Ireland
Martin-Loeches, Martin drmartinloeches@gmail.com
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151 Department of Anaesthesiology and Intensive
Care, Zaporozhye State Medical University,
Zaporozhye, Ukraine
Vorotyntsev, Sergiy vorotyntsev_s@ukr.net
152 Department of Anaesthesiology and Intensive
Care, Lutsk Clinical Hospital, Lutsk, Ukraine
Fronchko, Valentyna fron@ua.fm
161 Division of Anesthesiology, Critical Care and
Pain Medicine, Tel Aviv Medical Center, Sackler
School of Medicine, Tel Aviv, Israel
Matot, Idit
Goren, Or
Zac, Lilach
iditm@tlvmc.gov.il
goren.orr@gmail.com
isanaesfile@gmail.com
171 Department of Anaesthesiology and Intensive
Therapy, Barlicki University Hospital, Medical
University of Lodz, Poland
Gaszynski, Thomasz tomasz.gaszynski@umed.lodz.pl
181 Department of Anesthesiology and Critical
Care, Saint Michael’s Hospital, University of
Toronto, Canada
Laffey, Jon laffeyj@smh.ca
191 Operating Services, Critical Care and Anaesthesia
(OSCCA), Sheffield Teaching Hospitals,
United Kingdom
Mills, Gary g.h.mills@sheffield.ac.uk
192 Department of Anaesthesia and Critical Care
Medicine, University Hospital of North Midlands,
Stoke-on-Trent, United Kingdom
Nalwaya, Pramod pramod.nalwaya@uhns.nhs.uk
193 Research Divisional Lead – Surgery and Oncology,
Research and Development Department, Ashford
and St Peter Hospitals NHS Trust, Chertsey,
United Kingdom
Mac Gregor, Mark mark.macgregor@asph.nhs.uk
194 Department of Anaesthesia, Royal Cornwall
Hospital, Truro, United Kingdom
Paddle, Jonathan jonathan.paddle@nhs.net
195 Department of Anaesthesia, Hull and East
Yorkshire NHS Trust, Hull, United Kingdom
Balaji, Packianathaswamy indbalaji@gmail.com
196 Department of Critical Care Medicine, Imperial
College Healthcare NHS Trust, London,
United Kingdom
Rubulotta, Francesca
Adebesin, Afeez
frubulotta@hotmail.com
afeez.adebesin@imperial.nhs.uk
197 Department of Anaesthesia, Western Sussex
Hospitals NHS Foundation Trust, Chichester,
United Kingdom
Margarson, Mike michael.margarson@wsht.nhs.uk
198 Department of Anaesthesia, York Teaching
Hospitals, York, United Kingdom
Davies, Simon drsimondavies@googlemail.com
199 Department of Anaesthesia, Homerton University
Hospitals NHS Foundation Trust, Homerton,
United Kingdom
Rangarajan, Desikan desikan.rangarajan@homerton.nhs.uk
190 Department of Anesthesia, Southmead Hospital,
Bristol, United Kingdom
Newell, Christopher christopher.newell@doctors.org.uk
201 Department of Anaesthesia and Critical Care
Medicine, University Clinic of Surgery St. Naum
Ohridski, Skopje, Macedonia
Shosholcheva, Mirjana sosolceva@hotmail.com
211 Department of Anaesthesia, Polyclinique Montier
La Celle, St. Andre les Vergers, France
Papaspyros, Fotios papaspyrosf@outlook.com
221 Department of Anaesthesia, Alexandra General
Hospital, Athens, Greece
Skandalou, Vasiliki vps_71@hotmail.com
Department of Anaesthesiology and Intensive
Medicine, University Hospital of Ostrava,
Ostrava-Poruba, Czech Republic
Dzurňáková, Paula paula.dzurnakova@fno.cz
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Table 5 Ethics committees that approved the study
001 Dresden Department of Anesthesiology and Intensive
Care Medicine, Pulmonary Engineering Group,
University Hospital Dresden, Germany
Ethics Committee of the Medical Faculty of the Technical
University Dresden
ID: EK 430112013
002 Aachen Department of Anesthesiology, University of
Aachen, Germany
Ethics Committee of the Medical Faculty of RWTH Aachen
ID: EK 181/14
003 Düsseldorf Department of Anesthesiology CLIPS Clinical
Trials – Patient-centered Studies, University
Hospital Düsseldorf, Germany
Ethics Committee of the Medical Faculty of HHU Düsseldorf
ID: 2014072709
004 Mainz Department of Anaesthesiology, University
Medical Center Mainz, Germany
Ethics Committee of the Medical Faculty of UMC Mainz
ID: 837.307.14 (9546)
005 Bochum Clinic of Anesthesiology, Intensive Care and
Pain Medicine, University Clinic
Knappschaftskrankenhaus Bochum, Germany
Ethics Committee of the Medical Faculty, Ruhr University
Bochum
ID: 5110-14
006 Heidelberg Department of Anesthesiology, University
Hospital Heidelberg, Germany
Ethics Committee of the Medical Faculty, University of
Heidelberg
ID: S-442/2014
007 Wesel Department of Anesthesiology, Marienhospital
Wesel, Germany
Ethics Committee of the Medical Council Nordrhein,
Düsseldorf
ID: 2014497
008 Friesoythe Department of Anesthesiology and Intensive
Care Medicine, Marienstift Friesoythe, Germany
Ethics Committee of the Medical Council Niedersachsen,
Hannover
ID: Grae/045/2015
009 Bonn Department of Anesthesiology and Intensive
Care Medicine, University Hospital Bonn, Germany
Ethics Committee of the Medical Faculty of the University
of Bonn
ID: 288/15
011 Porto Serviço de Anestesiologia, Centro Hospitalar
do Porto, Portugal
Ethics and Health Committee of Centro Hospitalar do Porto
ID: 2014.144 (100-DEFI/130-CES)
012 Santa Maria da Feira Serviço de Anestesiologia, Centro Hospitalar
Entre o Douro e Vouga, Santa Maria da Feira,
Portugal
Ethics and Health Committee of Centro Hospitalar Entre o
Douro e Vouga, Santa Maria da Feira
ID: 07/ANES/2014
013 Porto Serviço de Anestesiologia, Centro Hospitalar
São João, Porto, Portugal
Ethics and Health Committee of Centro Hospitalar São João, Porto
ID: CES 167-14
014 Matosinhos Serviço de Anestesiologia, Hospital Pedro
Hispano, Matosinhos, Portugal
Ethics and Health Committee of Hospital Pedro Hispano,
Matosinhos
ID: 076/CE/JAS
021 New York Department of Anesthesiology, Montefiore
Medical Center Bronx, New York, NY, USA
Institutional Review Board at Montefiore Medical Center
Bronx, New York
ID: 2014-3761
022 Rochester, Minnesota Department of Anesthesiology, Mayo Clinic,
Rochester, MN, USA
Institutional Review Board Mayo Clinic
ID: 14-005465
023 Jacksonville, Florida Department of Anesthesiology, Mayo Clinic,
Jacksonville, FL, USA
Institutional Review Board Mayo Clinic
ID: 14-005465
024 Phoenix, Arizona Department of Anesthesiology, Mayo Clinic,
Phoenix, AZ, USA
Institutional Review Board Mayo Clinic
ID: 14-005465
025 Aurora, Colorado Department of Anesthesiology, University of
Colorado SOM, Aurora, CO, USA
ŒColorado Multiple Institutional Review Board (COMIRB)
ID: 14-1495
026 Boston Department of Anesthesiology, Tufts Medical
Center, Boston, MA, USA
Institutional Review Board at Tufts Medical Center, Boston
ID: 11808
027 Jackson Department of Anesthesiology, University of
Mississippi, Jackson, MS, USA
Institutional Review Board at University of Mississippi, Jackson
ID: 2015-0080
028 Chicago Department of Anesthesiology, University of
Chicago, Chicago, IL, USA
Institutional Review Board at University of Chicago, Chicago
ID: 14-1044
031 Santiago de Chile Department of Anesthesiology, Pontificia
Universidad Católica de Chile, Santiago
de Chile, Chile
Comite de Etica en Investigacion Escuela de Medicina Pontificia
Universidad Catolica de Chile
ID: 14-462
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041 Amsterdam Department of Intensive Care, Academic
Medical Center, University of Amsterdam,
The Netherlands
Medisch Ethische Toetsingscommissie (METC) of the Academic
Medical Center (AMC), Amsterdam
ID: 2014_261
042 Leiden Department of Anesthesiology, Leiden University
Medical Center, Leiden, The Netherlands
Ethics Committee of the Leiden University Medical Center
(LUMC), Leiden
ID: P15.038
043 Hoorn Department of Anesthesiology, Westfriesgasthuis,
Hoorn, The Netherlands
Ethics Committee of Westfriesgasthuis, Hoorn
ID: WB 486
044 Amsterdam Department of Anesthesiology, VU Medical
Center, Amsterdam, The Netherlands
Ethics Committee of VU Medical Center (VUMC), Amsterdam
ID: 2014.561
045 Amsterdam Department of Anesthesiology, Onze Lieve
Vrouwen Gasthuis (OLVG), Amsterdam,
The Netherlands
Ethics Committee of the Onze Lieve Vrouwen Gasthuis (OLVG),
Amsterdam
ID: WO 14.133
051 Vienna Department of Anesthesiology and General
Intensive Care, Medical University of Vienna,
Austria
Ethics committee of the Medical University of Vienna
ID: 1702/2014
061 Badalona Department of Anesthesiology, Hospital
Universitari Germans Trias i Pujol, Badalona,
Spain
Comité d’Ètica de la Investigació. Hospital Universitari Germans
Trias i Pujol, Badalona
ID: AC-14-095
062 Valencia Department of Anesthesiology and Critical
Care, Hospital Clinico Universitario de
Valencia, Spain
Ethics Committee of the Hospital Clinico Universitario de Valencia
ID: F-CE-GEva-15, approved 27/11/2014
063 Valencia Department of Anesthesiology, Critical Care and
Pain Relief, Consorcio Hospital General
Universitario de Valencia, Spain
Ethics Committee of the Consorcio Hospital General Universitario
of Valencia
ID: 223/2004
064 Madrid Department of Anesthesiology and Surgical
Critical Care, Hospital Universitario La Paz,
Madrid, Spain
Ethics Committee of the Hospital Universitario La Paz, Madrid
ID: 4465 12/2015
065 Terrassa Department of Anesthesiology, Hospital
Universitari Mútua de Terrassa, Spain
Ethics Committee of the Hospital Universitari Mútua de Terrassa,
Terassa
ID: 04/15, approved 29/04/2015
066 Barcelona Department of Anesthesiology, Hospital
Clinic de Barcelona, Spain
Research Ethics Committee of the Hospital Clínic of Barcelona
ID: HCB/2015/0963
071 Makkah Department of Anesthesiology, King Abdullah
Medical City, Makkah, Saudi Arabia
King Abdullah Medical City (KAMC) Local IRB registered at
the National BioMedical Ethics Committee, King Abdulaziz
City for Science and Technology
ID: 14-144
072 Riyadh Department of Anesthesiology, King Abdulaziz
National Guard Medical City, Riyadh, Saudi Arabia
Ethics Committee of the King Abdulaziz National Guard Medical
City, Riyadh
ID: IRBC/215/16
081 Istanbul Department of Anaesthesiology, Istanbul Medical
Faculty, Istanbul University, Istanbul, Turkey
Clinical Research Ethics Committee of the Istanbul Faculty
of Medicine, Istanbul University, Istanbul
IB: 1417, approved 18/9/2014
082 Istanbul Department of Anesthesiology and Reanimation,
Marmara University School of Medicine,
Istanbul, Turkey
Clinical Research Ethics Committee of the Istanbul Faculty
of Medicine, Istanbul
ID: 09.2015075
083 Antalya Department of Anesthesiology and Reanimation,
Akdeniz University Hospital, Antalya, Turkey
Ethics Committee of Akdeniz University Hospital, Antalya
ID: 170, approved 17/04/2015
084 Izmir Department of Anesthesiology and Reanimation,
Dokuz Eylül University of Medicine, Izmir, Turkey
Ethics Committee of Dokuz Eylul University Medical Faculty
ID: 66, approved 23/01/2015
085 Istanbul Department of Anesthesiology and Reanimation,
Fatih Sultan Mehmet Educational and Research
Hospital, Istanbul, Turkey
Ethics committee of Fatih Sultan Mehmet Educational and
Research Hospital, Istanbul
ID: 17073117-050-99
091 Napoli Department of Anaesthesiological, Surgical and
Emergency Sciences, Second University of
Naples, Italy
Ethics committee of Second University of Naples
ID: 29.GEN.2015/128
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092 Ferrara Department of Morphology, Surgery and
Experimental Medicine, Ospedale Sant’ Anna,
Ferrara, Italy
Ethics Committee of Ferrara
ID: 15097, approved 26/03/2015
093 Varese Department of Environment, Health and Safety,
University of Insubria, Varese, Italy
Ethics Committee – ASST Sette Laghi Ospedale di Circolo
e Fondazione Macchi, Varese, Italy
ID: 0034259
094 Genoa Dept. of Surgical Sciences and Integrated
Diagnostics, IRCCS AOU San Martino, IST,
University of Genoa, Italy
Regional Ethics Committee Liguria, Italy
ID: 121.REG.2015
095 Aosta Department of Anesthesiology and Reanimation,
Ospedale U. Parini, AUSL della Valle d’ Aosta, Italy
Ethics Committee of AUSL della Valle d’ Aosta, Aosta
ID: 737, approved 19/06/2015
101 Geneva Department of Anesthesiology, Pharmacology
& Intensive Care, University Hospital Geneva,
Switzerland
Ethics Committee of University Hospital Geneva
ID: 14-238
102 Frauenfeld Department of Anesthesiology and Intensive
Care, Kantonsspital Frauenfeld, Switzerland
Ethics Committee of the Kanton Thurgau, Münsterlingen
ID: A2015/33
103 Basel Department of Anesthesia, Surgical Intensive
Care, Prehospital Emergency Medicine and
Pain Therapy, University Hospital Basel,
Switzerland
Ethikkommission Nordwest- und Zentralschweiz
ID: PB_2016-00313
111 Zagreb University Department of Anesthesiology,
Resuscitation and Intensive Care, University
Hospital Sveti Duh, Zagreb, Croatia
Ethics Committee of the Clinical Hospital Sveti Duh
ID: 01-12/4
112 Zagreb Department of Anesthesiology, Resuscitation
and Intensive Care, Clinical Hospital Dubrava,
Zagreb, Croatia
Ethics Committee of the University Zagreb School of Medicine
and Ethics Committee of Clinical Hospital Dubrava Zagreb
ID: none provided, approved 23/06/2015
121 Ghent Department of Anesthesiology, Ghent University
Hospital, Belgium
Ethics Committee of Ghent University Hospital
ID: B670201523757
123 Antwerpen Department of Anesthesiology, UH Antwerpen,
Belgium
Ethics Committee of Ghent University Hospital
ID: B670201523757
124 Leuven Department of Anesthesiology, UZ Leuven,
Belgium
Ethics Committee of Ghent University Hospital
ID: B670201523757
125 Bruges Department of Anaesthesiology, Intensive care
and Emergency, AZ Sint Jan Brugge, Bruges,
Belgium
Ethics Committee of Ghent University Hospital
ID: B670201523757
126 Brussels Department of Anesthesiology, Cliniques
Universitaires St Luc, Belgium
Ethics Committee of Ghent University Hospital
ID: B670201523757
131 Bucharest Department of Anesthesiology, Ponderas
Hospital, Bucharest, Romania
Ethic Council of the Ponderas Hospital, Bucharest
ID: 73, approved /23/06/2015
141 Dublin Department of Critical Care and burns unit, SR
James’s University Hospital, Dublin, Ireland
Ethics Committee of St. James’s University Hospital, Dublin
ID: 2015/05/02
151 Zaporozhye Department of Anaesthesiology and Intensive
Care, Zaporozhye State Medical University,
Zaporozhye, Ukraine
Ethics Committee of the Zaporozhye State Medical University,
Zaporozhye
ID: 5/2015
152 Lutsk Department of Anaesthesiology and Intensive
Care, Lutsk Clinical Hospital, Lutsk, Ukraine
Ethics Committee of the Lutsk Clinical Hospital, Lutsk
ID: 354/1.3.7.15
161 Tel Aviv Division of Anesthesiology, Critical Care and Pain
Medicine, Tel Aviv Medical Center, Sackler
School of Medicine, Tel Aviv, Israel
Tel Aviv Medical Center Helsinki Committee
ID: 0509-14-TLV
171 Lodz Department of Anaesthesiology and Intensive
Therapy, Barlicki University Hospital, Medical
University of Lodz, Poland
Ethics Committee of Medical University of Lodz, Poland
ID: RNN/134/15/KE
181 Toronto Department of Anesthesiology and Critical Care,
Saint Michael’s Hospital, University of Toronto,
Canada
St Michael’s Hospital Research Ethics Board
ID: 15-134
191 Sheffield Operating Services, Critical Care and Anaesthesia
(OSCCA), Sheffield Teaching Hospitals, United
Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
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Additional file 1: PROBESE Study protocol version 2.5. This PDF file includes
the most recent version of the PROBESE Study protocol with changes
highlighted. (PDF 870 kb)
Additional file 2: Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) 2013 checklist: recommended items to
address in a clinical trial protocol and related documents. (PDF 122 kb).
Additional file 3: PROBESE case report form version 1.2.2. This file
corresponds to the paper version of the case report form. (DOC 1610 kb).
Additional file 4: Standard operating procedures (SOP) for plasma
Sampling. (PDF 115 kb)
Additional file 5: Standard operating procedures (SOP) for plasma
Sampling. (PDF 110 kb)
Abbreviations
AE: Adverse event; ARDS: Acute respiratory distress syndrome; ARISCAT: Assess
Respiratory Risk in Surgical Patients in Catalonia; BMI: Body mass index;
CONSORT: Consolidated Standards of Reporting Trials; COPD: Chronic obstructive
pulmonary disease; CRF: Case report form; DIC: Disseminated intravascular
coagulation; DSMB: Data and Safety Monitoring Board; FiO2: Fraction of
inspired oxygen; GIF: Gastrointestinal failure; I:E: Inspiratory-to-expiratory
ratio; ICU: Intensive care unit; INR: International normalized ratio;
ITT: Intention-to-treat; OSA: Obstructive sleep apnea; PaO2: Partial
pressure of arterial oxygen; PBW: Predicted body weight; PEEP: Positive
end-expiratory pressure; PEPC: Postoperative extrapulmonary
complication; POD: Postoperative day; PPC: Postoperative pulmonary
complication; Ppeak: Peak airway pressure; Pplat: Plateau airway pressure; PROBESE
trial: PRotective Ventilation with Higher versus Lower PEEP during General Anesthesia
for Surgery in OBESE Patients; REDCap™: Research Electronic Data Capture (web-based
system used during PROBESE as electronic case report form); RIFLE classification
system: Risk, injury, failure, loss, end-stage kidney disease; RM: Recruitment maneuver;
RR: Respiratory rate; SPIRIT: Standard Protocol Items: Recommendations for
Interventional Trials; SpO2: Peripheral oxyhemoglobin saturation measured by pulse
oximetry; SSL: Secure Sockets Layer; VAS: Visual analogue scale; VT: Tidal volume;
WHO: World Health Organization
Acknowledgements
We thank Marko Kaeppler for building and maintaining the electronic
CRF, as well as the team of the Clinical Trial Network of the European
Society of Anaesthesiology (ESA) for organizational support, study
promotion, and on-site monitoring: Brigitte Leva, Sandrine Damster,
Benoit Plichon, Julia Dowell, and Pierre Harlet. We are also thankful to
Edward J. Mascha, PhD, from the Department of Quantitative Health Sci-
ences and the Department of Anesthesia Outcomes Research, Cleveland Clinic,
Cleveland, OH, USA, for statistical advice regarding adjustment of sample sizes.
We are indebted to all the PROBESE
investigators listed in Appendix 1.
Table 5 Ethics committees that approved the study (Continued)
192 Stoke-on-Trent Department of Anaesthesia and Critical Care
Medicine, University Hospital of North Midlands,
Stoke-on-Trent, United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
193 Chertsey Research Divisional Lead – Surgery and Oncology,
Research and Development Department, Ashford
and St Peter Hospitals NHS Trust, Chertsey,
United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
194 Truro Department of Anaesthesia, Royal Cornwall
Hospital, Truro, United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
195 Hull Department of Anaesthesia, Hull and East
Yorkshire NHS Trust, Hull, United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
196 London Department of Critical Care Medicine, Imperial
College Healthcare NHS Trust, London,
United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
197 Chichester Department of Anaesthesia, Western Sussex
Hospitals NHS Foundation Trust, Chichester,
United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
198 York Department of Anaesthesia, York Teaching
Hospitals, York, United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
199 Homerton Department of Anaesthesia, Homerton University
Hospitals NHS Foundation Trust, Homerton,
United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
190 Bristol Department of Anaesthesia, Southmead Hospital,
Bristol, United Kingdom
NISCHR Research Ethics Service, Wales REC4,Wrexham
ID: 15/WA/0106
201 Skopje Department of Anaesthesia and Critical Care
Medicine, University Clinic of Surgery St. Naum
Ohridski, Skopje, Macedonia
Ethic Committee of the University Hospital Skopje
ID: 07/3183/1
211 St. Andre les Vergers Department of Anaesthesia, Polyclinique Montier
La Celle, St. Andre les Vergers, France
Ethic Committee of the Polyclinique Montier La Celle, St.
Andre les Vergers
ID: non provided; approved 16/03/2016
221 Athens Department of Anaesthesia, Alexandra General
Hospital, Athens, Greece
Ethic Committee of the Alexandra General Hospital, Athens
ID: 18-8/21-06-2016
Ostrava-Poruba Department of Anaesthesiology and Intensive
Medicine, University Hospital of Ostrava,
Ostrava-Poruba, Czech Republic
Ethic Committee of the University Hospital of Ostrava,
Ostrava-Poruba
ID: 64/2015
Bluth et al. Trials  (2017) 18:202 Page 19 of 22
Funding
This trial was funded in part by a grant from the European Society of Anesthesiology
Clinical Trial Network (ESA CTN; reference no. CTN-2014-PROBESE). At the Mayo Clinic,
Rochester, MN, USA, funding was provided by The Mayo Clinic Small Grants Program
(reference no. UL1 TR000135 from the National Center for Advancing Translational
Sciences [NCATS]). At U.K. sites, funding was provided by the Portfolio Program of the
National Health Service (NHS reference no. 19983).
Availability of data and materials
The datasets analyzed during the present study are available from the
corresponding author on reasonable request.
Authors’ contributions
TB conceived and designed the study, coordinates the overall study and
drafted the manuscript. RT participated in the design of the study and
contributed to the final manuscript. TK participated in the design of the
study and contributed to the final manuscript. IB participated in the design
of the study and contributed to the final manuscript. JC participated in the
design of the study, coordinates the study in Spain and contributed to the
final manuscript. GC participated in the design of the study and contributed
to the final manuscript. LdB participated in the design of the study,
coordinates the study in Belgium and contributed to the final manuscript.
CG participated in the design of the study and contributed to the final
manuscript. GH participated in the design of the study and contributed to
the final manuscript. SNH participated in the design of the study, co-
coordinates the study in the Netherlands and contributed to the final manu-
script. MH participated in the design of the study and contributed to the
final manuscript. MWH participated in the design of the study, coordinates
the study in The Netherlands and contributed to the final manuscript. SJ par-
ticipated in the design of the study and contributed to the final manuscript.
JGL participated in the design of the study, coordinates the study in Canada
and contributed to the final manuscript. MJL participated in the design of
the study, coordinates the study in Switzerland and contributed to the final
manuscript. KM participated in the design of the study, coordinates the study
in Austria and contributed to the final manuscript. IM participated in the de-
sign of the study and contributed to the final manuscript. GM performed the
sample size calculation, drafted the statistical analysis plan and contributed
to the final manuscript. GHM participated in the design of the study, coordi-
nates the study in the United Kingdom and contributed to the final manu-
script. JPM participated in the design of the study and contributed to the
final manuscript. CP participated in the design of the study and contributed
to the final manuscript. RR participated in the design of the study and con-
tributed to the final manuscript. JSc drafted the statistical analysis plan and
contributed to the final manuscript. MS participated in the design of the
study, coordinates the study in Turkey and contributed to the final manu-
script. ASN participated in the design of the study, monitors and reports ad-
verse events and contributed to the final manuscript. PS participated in the
design of the study and contributed to the final manuscript. JSp participated
in the design of the study, coordinates the study in the United States and
contributed to the final manuscript. MFVM participated in the design of the
study and contributed to the final manuscript. HW participated in the design
of the study, coordinates the study in Germany and contributed to the final
manuscript. MJS conceived and designed the study and drafted the manu-
script. PP conceived and designed the study and drafted the manuscript.
MGdA conceived and designed the study and drafted the manuscript.
All authors read and approved the final manuscript.
Authors’ information
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The institutional review board (IRB) at the University Hospital Dresden, Technische
Universität Dresden, Dresden, Germany, approved the study protocol version 2.5
(reference no. EK 430112013). The respective review boards of participating sites,
which are listed in Appendix 2, also approved the study. PROBESE is designed in
accordance with the principles of the Declaration of Helsinki. Written informed
consent was obtained from every enrolled patient upon request by the local IRB.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Pulmonary Engineering Group, Department of Anesthesiology and Intensive
Care Medicine, University Hospital Carl Gustav Carus, Dresden, Germany.
2Aneszteziológiai és Intenzív Terápiás Klinika, Semmelweis Egyetem,
Budapest, Hungary. 3Department of Anesthesiology, Hospital Universitari
Germans Trias i Pujol, Badalona, Spain. 4Department of Anesthesiology and
Intensive Care Medicine, University of Foggia, Foggia, Italy. 5Department of
Anesthesiology, Ghent University Hospital, Ghent, Belgium. 6Department of
Biopathology and Medical Biotechnologies, Policlinico “P. Giaccone”, Palermo,
Italy. 7Section of Clinical Physiology, Department of Medical Sciences,
University Hospital, Uppsala, Sweden. 8Department of Anesthesiology,
Academic Medical Center, University of Amsterdam, Amsterdam, The
Netherlands. 9Laboratory of Experimental Intensive Care and Anesthesiology
(L·E·I·C·A), Academic Medical Center, University of Amsterdam, Amsterdam,
The Netherlands. 10Division of Cardiac Surgery, Medical University of Vienna,
Vienna, Austria. 11Division of Thoracic Surgery, Medical University of Vienna,
Vienna, Austria. 12Division of Vascular Surgery, Medical University of Vienna,
Vienna, Austria. 13Department of Anesthesia, Intensive Care and Pain
Medicine, Medical University of Vienna, Vienna, Austria. 14Department of
Critical Care Medicine and Anesthesiology (SAR B), Saint Eloi University
Hospital, Montpellier, France. 15Critical Care Medicine Program, Department
of Anesthesia, Saint Michael’s Hospital, Toronto, ON, Canada. 16Department
of Anesthesia, University of Toronto, Toronto, ON, Canada. 17Department of
Physiology, University of Toronto, Toronto, ON, Canada. 18Interdepartmental
Division of Critical Care Medicine, University of Toronto, Toronto, ON,
Canada. 19Department of Anesthesiology, Pharmacology and Intensive Care,
University Hospital Geneva, Geneva, Switzerland. 20Department of Anesthesia,
Intensive Care and Pain Medicine, Medical University of Vienna, Vienna,
Austria. 21Department of Anesthesiology and Critical Care, Tel Aviv Medical
Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
22Center for Evidence-based Healthcare, University Hospital and Medical
Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
23Operating Services, Critical Care and Anaesthesia (OSCCA), Sheffield
Teaching Hospitals and University of Sheffield, Sheffield, UK. 24Department of
Anesthesiology, AZ Sint Jan Brugge-Oostende AV, Brugge, Belgium.
25Department of Anesthesiology and Intensive Care Medicine, University of
Bonn, Bonn, Germany. 26Department of Anesthesiology, University of
Aachen, Aachen, Germany. 27Department of Anesthesiology and Intensive
Care Medicine, Istanbul Medical Faculty, University of Istanbul, Istanbul,
Turkey. 28Department of Critical Care Medicine, Hospital Israelita Albert
Einstein, Faculdade de Medicina do ABC, São Paulo, Brazil. 29Program of
Post-Graduation, Research and Innovation, Faculdade de Medicina do ABC,
São Paulo, Brazil. 30Department of Biotechnology and Sciences of Life,
University of Insubria, ASST dei Sette Laghi, Ospedale di Cricolo e
Fondazione Macchi, Varese, Italy. 31Department of Anesthesiology, Mayo
Clinic, Rochester, MN, USA. 32Department of Anesthesia, Critical Care and
Pain Medicine, Massachusetts General Hospital, Harvard Medical School,
Boston, MA, USA. 33Department of Anesthesiology and Intensive Care
Medicine, University of Leipzig, Leipzig, Germany. 34Department of Intensive
Care, Academic Medical Center, University of Amsterdam, Amsterdam, The
Netherlands. 35Department of Surgical Sciences and Integrated Diagnostics,
IRCCS AOU San Martino – IST, University of Genoa, Genoa, Italy.
Received: 4 October 2016 Accepted: 29 March 2017
References
1. Mazo V, Sabate S, Canet J, Gallart L, de Abreu MG, Belda J, et al. Prospective
external validation of a predictive score for postoperative pulmonary
complications. Anesthesiology. 2014;121:219–31.
2. Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante
A, Futier E, et al. Incidence of mortality and morbidity related to postoperative
lung injury in patients who have undergone abdominal or thoracic surgery: a
systematic review and meta-analysis. Lancet Respir Med. 2014;2:1007–15.
Bluth et al. Trials  (2017) 18:202 Page 20 of 22
3. Canet J, Sabaté S, Mazo V, Gallart L, de Abreu MG, Belda J, et al.
Development and validation of a score to predict postoperative
respiratory failure in a multicentre European cohort: a prospective,
observational study. Eur J Anaesthesiol. 2015;32:458–70.
4. Guldner A, Kiss T, Serpa Neto A, Hemmes SN, Canet J, Spieth PM, et al.
Intraoperative protective mechanical ventilation for prevention of postoperative
pulmonary complications: a comprehensive review of the role of tidal volume,
positive end-expiratory pressure, and lung recruitment maneuvers. Anesthesiology.
2015;123:692–713.
5. Weiser TG, Makary MA, Haynes AB, Dziekan G, Berry WR, Gawande AA.
Standardised metrics for global surgical surveillance. Lancet. 2009;374:1113–7.
6. Serpa Neto A, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM,
et al. Protective versus conventional ventilation for surgery: a systematic review
and individual patient data meta-analysis. Anesthesiology. 2015;123:66–78.
7. PROVE Network Investigators for the Clinical Trial Network of the European
Society of Anaesthesiology. High versus low positive end-expiratory pressure
during general anaesthesia for open abdominal surgery (PROVHILO trial): a
multicentre randomised controlled trial. Lancet. 2014;384:495–503.
8. Pelosi P, Croci M, Ravagnan I, Vicardi P, Gattinoni L. Total respiratory system,
lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly
obese patients. Chest. 1996;109:144–51.
9. Pelosi P, Croci M, Ravagnan I, Tredici S, Pedoto A, Lissoni A, et al. The effects
of body mass on lung volumes, respiratory mechanics, and gas exchange
during general anesthesia. Anesth Analg. 1998;87:654–60.
10. Pelosi P, Gregoretti C. Perioperative management of obese patients. Best
Pract Res Clin Anaesthesiol. 2010;24:211–25.
11. Jaber S, Coisel Y, Chanques G, Futier E, Constantin JM, Michelet P, et al. A
multicentre observational study of intra-operative ventilatory management
during general anaesthesia: tidal volumes and relation to body weight.
Anaesthesia. 2012;67:999–1008.
12. Futier E, Marret E, Jaber S. Perioperative positive pressure ventilation: an
integrated approach to improve pulmonary care. Anesthesiology. 2014;121:400–8.
13. Canet J, Gallart L, Gomar C, Paluzie G, Valles J, Castillo J, et al. Prediction of
postoperative pulmonary complications in a population-based surgical
cohort. Anesthesiology. 2010;113:1338–50.
14. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques
and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123:
659–64.
15. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking
adults. Bull Eur Physiopathol Respir. 1982;18:419–25.
16. Morrison LJ, Deakin CD, Morley PT, Callaway CW, Kerber RE, Kronick SL, et al.
Part 8: Advanced life support: 2010 International Consensus on Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care Science with Treatment
Recommendations. Circulation. 2010;122(16 Suppl 2):S345–421.
17. Definition Task Force ARDS. Acute respiratory distress syndrome: the Berlin
Definition. JAMA. 2012;307:2526–33.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001
SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit
Care Med. 2003;31:1250–6.
19. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for
the Redefinition of Myocardial Infarction. Universal definition of myocardial
infarction. Circulation. 2007;116:2634–53.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality
Initiative workgroup. Acute Dialysis Quality Initiative w: Acute renal failure -
definition, outcome measures, animal models, fluid therapy and information
technology needs: the Second International Consensus Conference of the
Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.
21. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and
management of disseminated intravascular coagulation. Br J Haematol.
2009;145:24–33.
22. Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score
in critically ill patients: a prospective observational study. Crit Care. 2008;12:R90.
23. Du ZG, Wei YG, Chen KF, Li B. An accurate predictor of liver failure and
death after hepatectomy: a single institution’s experience with 478 consecutive
cases. World J Gastroenterol. 2014;20:274–81.
24. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA.
Systematic review: acute liver failure - one disease, more than 40 definitions.
Aliment Pharmacol Ther. 2012;35:1245–56.
25. Kristensen MT, Jakobsen TL, Nielsen JW, Jørgensen LM, Nienhuis RJ, Jønsson
LR. Cumulated Ambulation Score to evaluate mobility is feasible in geriatric
patients and in patients with hip fracture. Dan Med J. 2012;59:A4464.
26. Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-
Bang score indicates a high probability of obstructive sleep apnoea. Br J
Anaesth. 2012;108:768–75.
27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research
electronic data capture (REDCap)—a metadata-driven methodology and
workflow process for providing translational research informatics support. J
Biomed Inform. 2009;42:377–81.
28. Talab HF, Zabani IA, Abdelrahman HS, Bukhari WL, Mamoun I, Ashour MA,
et al. Intraoperative ventilatory strategies for prevention of pulmonary
atelectasis in obese patients undergoing laparoscopic bariatric surgery.
Anesth Analg. 2009;109:1511–6.
29. Ladha K, Vidal Melo MF, McLean DJ, Wanderer JP, Grabitz SD, Kurth T, et al.
Intraoperative protective mechanical ventilation and risk of postoperative
respiratory complications: hospital based registry study. BMJ. 2015;351:h3646.
30. Neto AS, Hemmes SN, Barbas CS, Beiderlinden M, Fernandez-Bustamante A,
Futier E, et al. Association between driving pressure and development of
postoperative pulmonary complications in patients undergoing mechanical
ventilation for general anaesthesia: a meta-analysis of individual patient data.
Lancet Respir Med. 2016;4:272–80.
31. Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal
volumes as compared with traditional tidal volumes for acute lung injury
and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.
32. Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, et al.
Driving pressure and survival in the acute respiratory distress syndrome. N Engl
J Med. 2015;372:747–55.
33. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. Higher
vs lower positive end-expiratory pressure in patients with acute lung injury
and acute respiratory distress syndrome: systematic review and meta-analysis.
JAMA. 2010;303:865–73.
34. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;
369:2126–36.
35. Serpa Neto A, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, et al.
Association between tidal volume size, duration of ventilation, and sedation
needs in patients without acute respiratory distress syndrome: an individual
patient data meta-analysis. Intensive Care Med. 2014;40:950–7.
36. Neto AS, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, et al.
Lung-protective ventilation with low tidal volumes and the occurrence of
pulmonary complications in patients without acute respiratory distress
syndrome: a systematic review and individual patient data analysis. Crit Care
Med. 2015;43:2155–63.
37. Protti A, Cressoni M, Santini A, Langer T, Mietto C, Febres D, et al. Lung
stress and strain during mechanical ventilation: any safe threshold? Am J
Respir Crit Care Med. 2011;183:1354–62.
38. Samary CS, Santos RS, Santos CL, Felix NS, Bentes M, Barboza T, et al.
Biological impact of transpulmonary driving pressure in experimental acute
respiratory distress syndrome. Anesthesiology. 2015;123:423–33.
39. Watt DG, Horgan PG, McMillan DC. Routine clinical markers of the magnitude
of the systemic inflammatory response after elective operation: a systematic
review. Surgery. 2015;157:362–80.
40. Severgnini P, Selmo G, Lanza C, Chiesa A, Frigerio A, Bacuzzi A, et al. Protective
mechanical ventilation during general anesthesia for open abdominal surgery
improves postoperative pulmonary function. Anesthesiology. 2013;118:1307–21.
41. Futier E, Constantin JM, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A,
et al. A trial of intraoperative low-tidal-volume ventilation in abdominal
surgery. N Engl J Med. 2013;369:428–37.
42. Hamlin RJ, Sprung J, Hofer RE, Schroeder DR, Weingarten TN. Obesity trends
in the surgical population at a large academic center: a comparison between
1989–1991 to 2006–2008 epochs. Acta Chir Belg. 2013;113:397–400.
43. Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric
surgery. Curr Opin Anaesthesiol. 2016;29:421–9.
44. Delay JM, Sebbane M, Jung B, Nocca D, Verzilli D, Pouzeratte Y, et al. The
effectiveness of noninvasive positive pressure ventilation to enhance
preoxygenation in morbidly obese patients: a randomized controlled study.
Anesth Analg. 2008;107:1707–13.
45. Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al.
Prevention of atelectasis in morbidly obese patients during general anesthesia and
paralysis: a computerized tomography study. Anesthesiology. 2009;111:979–87.
46. Futier E, Constantin JM, Petit A, Jung B, Kwiatkowski F, Duclos M, et al.
Positive end-expiratory pressure improves end-expiratory lung volume but
not oxygenation after induction of anaesthesia. Eur J Anaesthesiol. 2010;27:
508–13.
Bluth et al. Trials  (2017) 18:202 Page 21 of 22
47. Futier E, Constantin JM, Pelosi P, Chanques G, Massone A, Petit A, et al.
Noninvasive ventilation and alveolar recruitment maneuver improve respiratory
function during and after intubation of morbidly obese patients: a randomized
controlled study. Anesthesiology. 2011;114:1354–63.
48. Pepin JL, Timsit JF, Tamisier R, Borel JC, Levy P, Jaber S. Prevention and care
of respiratory failure in obese patients. Lancet Respir Med. 2016;4:407–18.
49. Whalen FX, Gajic O, Thompson GB, Kendrick ML, Que FL, Williams BA, et al.
The effects of the alveolar recruitment maneuver and positive end-expiratory
pressure on arterial oxygenation during laparoscopic bariatric surgery. Anesth
Analg. 2006;102:298–305.
50. Defresne AA, Hans GA, Goffin PJ, Bindelle SP, Amabili PJ, DeRoover AM, et
al. Recruitment of lung volume during surgery neither affects the
postoperative spirometry nor the risk of hypoxaemia after laparoscopic
gastric bypass in morbidly obese patients: a randomized controlled study.
Br J Anaesth. 2014;113:501–7.
51. Hess DR, Kondili D, Burns E, Bittner EA, Schmidt UH. A 5-year observational
study of lung-protective ventilation in the operating room: a single-center
experience. J Crit Care. 2013;28:533. e9–15.
52. Bender SP, Paganelli WC, Gerety LP, Tharp WG, Shanks AM, Housey M, et al.
Intraoperative lung-protective ventilation trends and practice patterns: a
report from the Multicenter Perioperative Outcomes Group. Anesth Analg.
2015;121:1231–9.
53. Pelosi P, Ravagnan I, Giurati G, Panigada M, Bottino N, Tredici S, et al.
Positive end-expiratory pressure improves respiratory function in obese but
not in normal subjects during anesthesia and paralysis. Anesthesiology.
1999;91:1221–31.
54. Eriksen J, Andersen J, Rasmussen JP, Sorensen B. Effects of ventilation with
large tidal volumes or positive end-expiratory pressure on cardiorespiratory
function in anesthetized obese patients. Acta Anaesthesiol Scand. 1978;22:
241–8.
55. Perilli V, Sollazzi L, Modesti C, Annetta MG, Sacco T, Bocci MG, et al.
Comparison of positive end-expiratory pressure with reverse Trendelenburg
position in morbidly obese patients undergoing bariatric surgery: effects on
hemodynamics and pulmonary gas exchange. Obes Surg. 2003;13:605–9.
56. Albert SP, DiRocco J, Allen GB, Bates JH, Lafollette R, Kubiak BD, et al. The
role of time and pressure on alveolar recruitment. J Appl Physiol. 2009;106:
757–65.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Bluth et al. Trials  (2017) 18:202 Page 22 of 22
